Long-term survival after fertility-sparing surgery for epithelial ovarian cancer.
Int. J. Gynecol. Cancer., Oct;19(7):1199-204 (2009)
CA125 level as a predictor of progression-free survival and overall survival in ovarian cancer patients with surgically defined disease status prior to the initiation of intraperitoneal consolidation therapy.
Gynecol. Oncol., Jan;104(1):176-80 (2007)
The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.
Gynecol. Oncol., Dec;103(3):1083-90 (2006)
Clinicopathologic features of early adenocarcinoma of the cervix initially managed with cervical conization.
Gynecol. Oncol., Dec;103(3):960-5 (2006)
A fertility-sparing alternative to radical hysterectomy: how many patients may be eligible?
Gynecol. Oncol., Dec;95(3):534-8 (2004)
Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.
Gynecol. Oncol., Sep;94(3):650-4 (2004)
Gastrointestinal adenocarcinoma arising in a mature cystic teratoma of the ovary.
Gynecol. Oncol., Aug;94(2):597-9 (2004)
Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix.
Gynecol. Oncol., May;57(2):158-64 (1995)
Clinicopathologic features of BRCA-linked and sporadic ovarian cancer.
JAMA., May;283(17):2260-5 (2000)
Retrospective analysis of carboplatin and paclitaxel as initial second-line therapy for recurrent epithelial ovarian carcinoma: application toward a dynamic disease state model of ovarian cancer.
J. Clin. Oncol., Mar;20(5):1238-47 (2002)
Ovarian hyperstimulation and oophorectomy following accidental daily clomiphene citrate use over three consecutive months.
Reprod. Toxicol., 14(6):541-3 (2000)
The role of laparoscopy in second-look evaluations for ovarian cancer.
Gynecol. Oncol., Jan;80(1):44-7 (2001)
Clinicopathologic features of BRCA1-linked and sporadic ovarian cancer
JAMA: Journal of the American Medical Association
Continent urinary diversion in patients undergoing exenterative or palliative procedures for recurrent gynecologic cancers
Cancer Screening for Women
he management and follow-up of adenocarcinoma in situ of the uterine cervix